Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2012
10/17/2012EP2510091A1 Method and composition to increase radiation-induced tumor therapeutic effects
10/17/2012EP2510087A2 Pathogen restriction factors
10/17/2012EP2509636A2 Compositions for nucleic acid delivery
10/17/2012CN102741410A Modulation of HSP47 expression
10/17/2012CN102741405A System for increasing gene expression, and vector supporting said system
10/17/2012CN102735843A JMJD8 gene and expression product for inhibiting growth of hepatoma cells
10/17/2012CN102732608A Marker for diagnosing liver cancer and application thereof
10/17/2012CN102732561A Recombinant adenovirus carrier with deletion of IVa2 gene function and preparation method thereof
10/17/2012CN102732543A Tumor genetically-engineered vaccine utilizing mucin-1 and survivin as target sites
10/17/2012CN102732533A Vaccine produced by using Cryptocaryon irritans immbolization antigen to complement deoxyribonucleic acid, and production method and application thereof
10/17/2012CN102732519A Screening and application of special siRNA of multi-serotype foot and mouth disease virus 3C gene
10/17/2012CN102732515A Nucleotide sequence and application thereof
10/17/2012CN102727909A Novel method for inhibiting primary liver cancer growth and metastasis
10/17/2012CN102727908A Oral gene vaccine for enterovirus, and preparation and application thereof
10/17/2012CN102727907A Drug delivery system of small interfering RNA drug and preparation
10/17/2012CN102727895A Pharmaceutical composition for targeting treatment of intractable epilepsy
10/17/2012CN102727884A Combined live vaccine against porcine reproductive and respiratory syndrome and pseudorabies, and preparation method thereof
10/17/2012CN102727436A Nucleic acid liposome drug preparation
10/17/2012CN102382831B shRNA for inhibiting Japanese encephalitis virus replication and infection and application thereof
10/17/2012CN102286465B Pig IFITM3 gene for inhibiting mouth disease virus multiplication, and construction method and application
10/17/2012CN102133405B Preparation method and application of liposome-chitosan compound gene carrier
10/17/2012CN102080098B Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation
10/17/2012CN102041265B Immunoassay reagent for assaying influenza A H1N1 virus antigen
10/17/2012CN101991864B Leptospira interrogans DNA (Deoxyribose Nucleic Acid) vaccine as well as construction method and application thereof
10/17/2012CN101991852B Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation
10/17/2012CN101791408B Cationic polymer gene vector having low cytotoxicity and high transfection efficiency, preparation method and use thereof
10/17/2012CN101748151B Recombinant human hepatitis C virus antigen adenoviral vector and applications thereof
10/17/2012CN101497881B Vaccine reading frame crosslinking with human molecule adjuvant hC3d3 same sense mutant
10/17/2012CN101141982B Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen
10/16/2012US8288610 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/16/2012US8288439 Attenuation of reproduction in human cells or transmission of infections ; using polynucleotide
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287881 Synthetic gagpol genes and their uses
10/16/2012US8287855 V. cholerae hyperexpressing recombinant cholera toxin B subunit showing dual immunogenicity
10/16/2012US8287849 Biodegradable poly(beta-amino esters) and uses thereof
10/16/2012CA2634992C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
10/16/2012CA2479512C Tissue engineering
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2368357C Methods for treating congestive heart failure
10/11/2012WO2012139099A2 Herpes simplex virus vaccine
10/11/2012WO2012138846A2 Method and compositions comprising small rna agonist and antagonists to modulate inflammation
10/11/2012WO2012138739A2 Compositions and methods for treating cancer
10/11/2012WO2012138691A2 Diagnosis and treatment of taxane-resistant cancers
10/11/2012WO2012138487A2 Oligonucleotide modulation of splicing
10/11/2012WO2012138453A1 Efficient protein expression in vivo using modified rna (mod-rna)
10/11/2012WO2012138325A1 Methods and compositions for eliciting an immune response against hepatitis b virus
10/11/2012WO2012137967A1 Calcium phosphate microcapsule
10/11/2012WO2012136811A1 A skeletal muscle-specific enhancer
10/11/2012WO2012136476A1 Method of activating a target gene in a cell
10/11/2012WO2012098397A4 Combination therapy for cancer
10/11/2012WO2012097057A3 Methods, compositions and kits for modulating trans-differentiation of muscle satellite cells
10/11/2012US20120258535 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
10/11/2012US20120258453 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258120 Compositions and methods for the systemic treatment of arthritis
10/11/2012US20120258082 Production of ifn-lambda by conventional dendritic cells and uses thereof
10/11/2012CA2834729A1 A skeletal muscle-specific enhancer
10/10/2012EP2508608A1 Method of treating neurodegenerative disease
10/10/2012EP2508606A1 Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing the same
10/10/2012EP2508603A1 System for increasing gene expression, and vector supporting said system
10/10/2012EP2508599A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein
10/10/2012EP2508535A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells
10/10/2012EP2507374A2 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors
10/10/2012EP2506857A1 Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases
10/10/2012EP2213738B1 siRNA molecules targeting Bcl-2
10/10/2012CN1678188B Nucleic acid compositions for stimulating immune responses
10/10/2012CN1452496B Use of strains of parapox ovis virus against organ fibrosis
10/10/2012CN1359301B Pharmaceutical composition comprising antibody specifically binding epitope in A-beta-10 residual group and its application
10/10/2012CN102719521A Application of cystine/glutamic acid reverse transporter xCT inhibitor in treating liver cancer
10/10/2012CN102719478A Chimpanzee adenovirus vaccine carriers
10/10/2012CN102719443A Carboxyl-terminal specific anti-human amyloid protein monoclonal antibody gene and its encoded polypeptide and application
10/10/2012CN102719439A Mutant human epidermal growth factor gene, protein, preparation methods for mutant human epidermal growth factor gene and protein, and application of mutant human epidermal growth factor gene and protein
10/10/2012CN102719437A Application of mediated PLK1 RNAi (polo-like kinase-1 ribonucleic acid interference) of lentivirus vector in treatment of esophageal squamous carcinoma metastasis
10/10/2012CN102719436A Oligonucleotides and usage thereof in preparation of medicine for preventing and curing myocardial hypertrophy and heart failure
10/10/2012CN102719434A Specific modification for inhibiting RNA interference off-target effect
10/10/2012CN102719432A Double-stranded asymmetric small nucleic-acid-interference-molecule asiRNA inhibiting tumour apoptosis suppressor specifically and application thereof
10/10/2012CN102719408A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
10/10/2012CN102718903A Transgenic non-viral vector of guanidinated polyvinyl alcohol, preparation method thereof and application thereof
10/10/2012CN102716500A Cationic macromolecular proteolipid gene medicine carrier, preparation method and application
10/10/2012CN102716499A Streptococcus iniae trivalent DNA vaccine and construction method thereof
10/10/2012CN102716498A Drug liposome capable of efficient and highly specific killing of P53 gene mutation type of breast cancer cells
10/10/2012CN102716497A Alpha1,3 galactosyltransferase-transfected material, its preparation method and application
10/10/2012CN102145179B Application of IL-1ra-Fcepsilon fusion gene and coded protein thereof to treatment on allergic rhinitis
10/10/2012CN102028958B Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof
10/10/2012CN101868251B Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/10/2012CN101748120B Interference RNA interfering muscle specific E3 ubiquitin protein ligase gene, vector containing same and application thereof
10/10/2012CN101057975B Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/10/2012CN101010002B Cancer selective auxotrophs
10/09/2012US8283518 Administration of transposon-based vectors to reproductive organs
10/09/2012US8283461 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
10/09/2012US8283332 PFKFB4 inhibitors and methods of using the same
10/09/2012US8283330 Modulators of pharmacological agents
10/09/2012US8283328 nucleotides having modified linkages, used as adjuvants for vaccines useful for treating diseases including cancer, infection, allergies and asthma
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012US8282921 tRNA synthetase fragments
10/09/2012US8282916 Tumor therapy with replication competent sindbis viral vectors
10/09/2012CA2711685C Modified nodavirus rna for gene delivery
10/09/2012CA2710965C Growing renal tubule cells and ex vivo renal tubule tissue system
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2459347C Locked nucleic acid (lna) compositions and uses thereof
1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 870